As health care costs continue to rise, employers and payers are under increasing cost pressure to optimally manage their members’ care. This White Paper explores the impact of integrated Anthem medical and pharmacy benefits on medical costs.

To better understand the potential health and financial benefits of VBID models for consumers, we evaluated the impact of a large employer’s decision to remove employee and dependents’ out-of-pocket costs for primary care physician (PCP) visits.

Our Clinical Research experts have worked collaboratively in complex studies of rare/orphan diseases with multi-specialty teams and multiple stakeholders. Offerings to our clients include customized clinical trials, epidemiology, health and policy research, and patient registry services.

Early-stage breast cancer patients often need radiation therapy as part of their treatment. Evidence on how long the radiation treatment should last has been evolving. Our results highlight that payor policies can significantly accelerate adoption of evidence-driven care above and beyond what physicians are doing on their own.

The needs for higher quality and timely real-world evidence has risen to a never-before-seen level, with the clamoring voices of payors, patients and providers alike expressing, often in unison, the need for such evidence to help determine the highest value treatment for the right patient, at the right time.

Under certain circumstances, opening up the design options in the pre-approval phases of drug development to include Pragmatic Clinical Trials (PCT’s) has the potential to greatly enrich and complement the findings from traditional RCT’s and, earlier in the drug approval process, broaden the generation of evidence more relevant to treated patients.

Large-scale alliance collaborations present a massive opportunity for stakeholders to work together to inform the decisions that have the power to make healthcare safer, lower cost, and higher quality.

From its inception, the mission of our Digital Research Solutions team has been the dissemination of important research findings to target audiences ranging from underserved populations, to providers and policy makers.

With ADHD diagnosis and medication prescriptions on the rise, it is crucial to better understand the trend for diagnosis and treatment pattern for ADHD among American children over time.